What Is Globozoospermia and How Is It Treated?

Globozoospermia is a rare form of male infertility in which sperm cells are round-headed instead of the usual oval shape, almost always because they lack the acrosome, a cap-like structure that sperm need to penetrate an egg. The condition affects a very small fraction of infertile men, and because the defect is structural and genetic, no medication or lifestyle change can fix it. Treatment centers on assisted reproduction, specifically a procedure called intracytoplasmic sperm injection (ICSI) combined with techniques that help the egg begin developing after fertilization. The science around globozoospermia has advanced considerably in the last two decades, and while it remains a challenging diagnosis, most affected men now have a realistic path to biological fatherhood.

What Goes Wrong in the Sperm

Healthy sperm have a structure at the front of the head called the acrosome, which works like a chemical drill. It releases enzymes that dissolve the outer layer of the egg so the sperm can fuse with it and deliver its DNA. In globozoospermia, the acrosome either never forms properly or detaches from the sperm nucleus during development. The result is a round-headed cell that cannot bind to or penetrate an egg on its own.1PubMed. Human globozoospermia-related genes and their role in acrosome biogenesis

The problem traces back to how sperm mature in the testes. During normal development, small vesicles bud off from a cellular structure called the Golgi apparatus and gradually merge into the acrosome, which then flattens over the front of the sperm nucleus like a helmet. In globozoospermic men, those vesicles either form abnormally or fail to anchor to the nuclear surface, so the acrosome never takes shape.2Human Reproduction. Acrosomal biogenesis in human globozoospermia: immunocytochemical, ultrastructural and proteomic studies Without the acrosome to sculpt the front end, the sperm head stays round instead of elongating into its characteristic teardrop.

Beyond the missing acrosome, globozoospermic sperm often carry additional structural problems. Electron microscopy studies show disorganized mitochondria in the tail, abnormal internal scaffolding around the nucleus, and sometimes duplicated heads or tails.3Reproductive BioMedicine Online. Complete globozoospermia associated with PLCζ deficiency treated with calcium ionophore and ICSI results in pregnancy These are not separate conditions layered on top of globozoospermia; they are downstream consequences of the same developmental failure.

Complete Versus Partial Forms

Clinicians distinguish between two forms. In complete (or total) globozoospermia, virtually every sperm in the ejaculate is round-headed and acrosomeless. In partial globozoospermia, more than half of the sperm are abnormal, but a fraction retains some acrosomal material. The cutoff used in most studies is roughly 50% acrosomeless sperm for a partial diagnosis.4PubMed. Morphology of partial globozoospermia

The distinction matters for treatment planning. Under the electron microscope, the two types look different at a fine structural level: completely affected sperm (type I) show no residual acrosome and have relatively normal tail architecture, while partially affected sperm (type II) may retain fragments of acrosomal material but tend to have worse tail defects, including disordered or missing mitochondria and disrupted internal microtubule structures.5Asian Journal of Andrology. Preliminary observations on phenotypic differences between complete and partial globozoospermia Partial globozoospermia sometimes responds better to standard ICSI, since a small population of near-normal sperm may be available for selection.

The Genetics Behind It

Globozoospermia is inherited in an autosomal recessive pattern, meaning a man must receive a defective copy of the responsible gene from both parents to be affected. The most commonly implicated gene is DPY19L2, which sits on chromosome 12 and is heavily expressed in the testes. In two landmark studies, researchers found that a roughly 200-kilobase deletion encompassing DPY19L2 accounted for the majority of cases they tested. One study identified the deletion in about 19% of unrelated patients with complete globozoospermia, while a second found it in 15 out of 20 patients.6PubMed Central. DPY19L2 deletion as a major cause of globozoospermia7The American Journal of Human Genetics. A Recurrent Deletion of DPY19L2 Causes Infertility in Man by Blocking Sperm Head Elongation and Acrosome Formation The DPY19L2 protein is thought to help anchor the developing acrosome to the nuclear envelope; without it, the acrosome drifts away and the head never elongates.

DPY19L2 is not the only gene involved. Mutations in SPATA16 and PICK1 have also been identified in globozoospermic men, and the list of candidate genes continues to grow as researchers sequence more patients.8PubMed Central. Single-center thorough evaluation and targeted treatment of globozoospermic men Other genes implicated in animal models include those governing Golgi apparatus organization and vesicle trafficking.9PubMed Central. An Overview of The Globozoospermia as A Multigenic Identified Syndrome Essentially, any gene whose protein plays a role in building or anchoring the acrosome can, when mutated, produce the globozoospermia phenotype. This makes it a genetically heterogeneous condition: different families may carry entirely different mutations yet end up with the same round-headed sperm.

How It Is Diagnosed

The first sign is almost always infertility. Globozoospermic men produce sperm in normal or near-normal numbers and have normal hormone levels, so nothing in a standard blood panel flags the condition. It surfaces during a semen analysis, when a technician examines the sperm under a microscope and notices the distinctive round heads and absent acrosomes.10PubMed Central. Successful Fertilization in a Case of Globozoospermia Through Assisted Oocyte Activation With Calcium Ionophores: A Case Report

Confirmation often involves specialized staining or transmission electron microscopy to visualize the missing acrosome directly. Clinics may also perform DNA integrity tests, since globozoospermic sperm tend to have higher rates of DNA fragmentation and chromatin packaging defects compared to normal sperm.11Urology. Analysis of Sperm Aneuploidies and DNA Fragmentation in Patients With Globozoospermia or With Abnormal Acrosomes In one case report, DNA fragmentation rates in unprocessed semen reached about 80%, though swim-up processing (a lab technique that selects the most motile sperm) brought that down to roughly 15–23%.3Reproductive BioMedicine Online. Complete globozoospermia associated with PLCζ deficiency treated with calcium ionophore and ICSI results in pregnancy Genetic testing for DPY19L2 deletions and mutations in SPATA16 or PICK1 can confirm the molecular cause and help guide genetic counseling.

Why Standard IVF Does Not Work

Conventional in vitro fertilization relies on sperm being able to bind to the egg’s outer shell and release acrosomal enzymes to get inside. Globozoospermic sperm cannot do either of those things, so simply mixing eggs and sperm in a dish fails completely. Even ICSI, which bypasses the binding step by injecting a single sperm directly into the egg, often produces disappointing results on its own. The fertilization rate with standard ICSI tends to be low because globozoospermic sperm are deficient in a protein called PLCζ (phospholipase C zeta), which normally triggers the chemical signal that tells the egg it has been fertilized.12Human Reproduction Update. Globozoospermia revisited

In normal fertilization, PLCζ is released from the sperm into the egg’s cytoplasm, setting off a series of calcium waves that activate the egg and start embryo development. Without enough PLCζ, the egg sits idle after injection. One study confirmed that in a patient with complete globozoospermia, PLCζ was undetectable by both immunofluorescence and protein analysis.3Reproductive BioMedicine Online. Complete globozoospermia associated with PLCζ deficiency treated with calcium ionophore and ICSI results in pregnancy Additionally, increased oxidative damage in globozoospermic sperm may further compromise fertilization outcomes.13PubMed. New insights into sperm with total globozoospermia: Increased fatty acid oxidation and centrin1 alteration

Artificial Oocyte Activation Changes the Picture

The breakthrough treatment for globozoospermia is combining ICSI with artificial oocyte activation (AOA). The idea is straightforward: since the sperm cannot trigger the calcium signal the egg needs, clinicians supply that signal from outside. The most widely used method is a calcium ionophore, a chemical that allows calcium to flood into the egg and mimic the natural activation cascade. This is typically applied shortly after ICSI.

The results have been encouraging. In one early case, a calcium ionophore raised the fertilization rate from about 36% with ICSI alone to roughly 56% with AOA, improved embryo quality, and led to a healthy pregnancy.14Fertility and Sterility. Successful pregnancy and childbirth after intracytoplasmic sperm injection with calcium ionophore oocyte activation in a globozoospermic patient A more recent study examining dual calcium ionophore activation after ICSI in confirmed globozoospermia cases with prior total fertilization failure found the approach delivered adequate fertilization and favorable cumulative live birth rates.15Reproductive BioMedicine Online. Dual calcium ionophore oocyte activation after ICSI in globozoospermia: fertilization and cumulative live birth outcomes Case reports have documented live births after ICSI-AOA in men with both complete and partial forms of the condition.16PubMed Central. Intracytoplasmic Sperm Injection with Assisted Oocyte Activation Resulting in Successful Pregnancies and Live Birth in Couples with Globozoospermia: A Report of Two Cases

Electrical activation is an alternative approach. Rather than bathing the egg in a chemical, clinicians deliver a brief electrical pulse after ICSI to trigger the calcium waves. In one case, all seven injected eggs fertilized normally after a single electrical pulse, resulting in a clinical pregnancy and the birth of a healthy girl at 37 weeks.17Fertility and Sterility. A successful pregnancy and live birth after intracytoplasmic sperm injection with globozoospermic sperm and electrical oocyte activation This method is less commonly used than calcium ionophore, partly because the equipment is less standardized across clinics, but it remains a viable option when chemical activation falls short.

DNA Damage and Chromatin Quality

One concern that shadows every treatment decision in globozoospermia is the quality of the DNA packaged inside the sperm. A systematic review found that sperm DNA fragmentation and protamine deficiency are both significantly higher in globozoospermic men compared to fertile controls.18Journal of Arak University of Medical Sciences. Study of Sperm Chromatin in Infertile Men with Globozoospermia: A Systematic Review Article Protamines are the specialized proteins that replace histones during sperm maturation, compacting the DNA tightly for transport. When that process goes wrong, the chromatin stays loosely packed, making the DNA more vulnerable to strand breaks.

Early case reports confirmed these concerns. One study documented that about 35% of sperm from a globozoospermic man had abnormally decondensed chromatin, and 37% showed DNA strand breaks, compared to roughly 5% and 23% in controls.19PubMed. Globozoospermia is associated with chromatin structure abnormalities: case report A separate study found a modest increase in sex chromosome aneuploidy and disomy 8 in globozoospermic patients, along with a correlation between abnormal acrosomes and chromosomal irregularities.11Urology. Analysis of Sperm Aneuploidies and DNA Fragmentation in Patients With Globozoospermia or With Abnormal Acrosomes

This is why sperm selection in the lab matters. Swim-up or density gradient preparation can filter out the worst-damaged cells and dramatically reduce the proportion of fragmented DNA that ends up in an egg. The fact that healthy pregnancies regularly result from ICSI-AOA in these patients suggests that the DNA damage, while elevated, does not make successful reproduction impossible when the best-quality sperm are chosen.

Is AOA Safe for Children

Whenever you artificially activate an egg, the natural question is whether the resulting child develops normally. The existing data, while still limited, is reassuring. A meta-analysis comparing children born from ICSI with AOA to those born from conventional ICSI found no increased rate of birth defects.20PubMed Central. Risk of birth defects in children conceived by artificial oocyte activation and intracytoplasmic sperm injection: a meta-analysis That held true for both chromosomal and non-chromosomal abnormalities in subgroup analyses.

A study tracking 47 children born after ICSI-AOA with calcium ionophore reported that no major malformations were detected in singleton births, and the minor malformations observed in seven singletons and one twin child were within normal population rates.21PubMed Central. Obstetric and neonatal outcome following ICSI with assisted oocyte activation by calcium ionophore treatment Longer-term follow-up on children aged 3 to 10 who were conceived via AOA showed developmental and neurocognitive outcomes within expected ranges.22Reproductive BioMedicine Online. Neonatal and neurodevelopmental outcome of children aged 3–10 years born following assisted oocyte activation

Researchers are candid that these numbers are still small. Globozoospermia is rare, so assembling large cohorts for long-term safety studies is inherently slow. The consensus for now is that AOA should be used selectively in couples who genuinely need it, such as those with confirmed fertilization failure after standard ICSI, rather than as a routine add-on.

Genetic Counseling and Passing It On

Because globozoospermia follows an autosomal recessive inheritance pattern, a man with the condition carries two copies of the causative mutation. If his partner does not carry a copy, their sons will each be carriers but unaffected. However, if the couple is consanguineous (related by blood), the chance that both parents carry the same mutation rises sharply. Pedigree studies of consanguineous families have confirmed this pattern repeatedly.23Andrologia. Identification of a DPY19L2 Mutation Linking Globozoospermia to Congenital Heart Defects in a Consanguineous Family: A Genetic Analysis

For couples where the man has DPY19L2-related globozoospermia and the marriage is consanguineous, some researchers have recommended screening embryos for the DPY19L2 deletion before transfer to reduce the chance of producing affected sons.24PubMed. Embryos derived from couples with consanguineous marriages with globozoospermia should be screened for gender or DPY19L2 deletion Preimplantation genetic testing can identify embryos that are homozygous for the deletion and allow the couple to choose unaffected embryos for transfer. This is a nuanced decision that benefits from thorough genetic counseling, especially because new mutations beyond DPY19L2 are still being discovered.

Epigenetic Differences in Globozoospermic Sperm

Beyond DNA sequence mutations, researchers have started examining epigenetic marks on globozoospermic sperm, the chemical modifications that sit on top of the DNA and help regulate which genes are active. One study mapped a specific modification called 5-hydroxymethylcytosine across the entire genome of normal, abnormal, and globozoospermic sperm. The globozoospermic samples showed distinctly different patterns, including the loss of this modification on a substantial fraction of imprinted genes, which are genes whose activity depends on whether they came from the mother or father.25PubMed Central. Genome-wide 5-hydroxymethylcytosine modification pattern is a novel epigenetic feature of globozoospermia

Imprinted genes are of particular interest in reproductive medicine because errors in their regulation can affect embryo development and childhood growth. Whether the epigenetic differences in globozoospermic sperm translate into measurable effects in children conceived through ICSI-AOA is still unknown. The research is in its early stages, but it points to globozoospermia involving more than just a missing acrosome and a round head. The developmental disruption appears to ripple outward through multiple layers of the sperm cell’s biology.

Animal Models and Future Therapies

Much of what scientists understand about the molecular machinery behind acrosome formation comes from mouse models. Researchers have engineered mice lacking various genes suspected to play a role in acrosome biogenesis and then studied the resulting sperm defects. For example, mice lacking the GM130 protein, which organizes the Golgi apparatus, produce round-headed sperm with complete absence of both acrosomes and mitochondrial sheaths, closely mirroring human globozoospermia.26Cell Death & Disease. Globozoospermia and lack of acrosome formation in GM130-deficient mice These models help researchers test ideas about which steps in sperm maturation go wrong and which proteins might be therapeutic targets.

One line of future treatment that has drawn attention is recombinant PLCζ. Since the inability of globozoospermic sperm to activate eggs stems largely from missing or deficient PLCζ, the idea is to inject a lab-produced version of the protein directly into the egg along with the sperm during ICSI. This would be a more physiologically natural way to trigger egg activation than a calcium ionophore, which floods the cell indiscriminately. As of now, recombinant PLCζ remains experimental, but researchers consider it a promising biological tool once the underlying pathways are better characterized.27PubMed. Reproductive outcome in globozoospermic men: update and prospects If it works as hoped, it could improve fertilization rates and embryo quality beyond what current chemical or electrical activation methods achieve, particularly for the subset of men whose sperm are most severely affected.

Kevin Maguire

Kevin Maguire, PhD, is a licensed psychologist and AASECT Certified Sex Therapist with 18 years of clinical experience. He earned his doctorate in clinical psychology at McGill University. In private practice he works with individuals and couples on low desire, arousal difficulties, painful sex and sexual concerns after illness or childbirth, and he supervises therapists training toward AASECT certification. His writing covers sexual health, desire and sexual function.